WASHINGTON — U.S. health officials are taking another look at the safety of breast implants, the latest review in a decades-long debate. In the documents, the FDA reiterated its position that “there is not sufficient evidence” linking them to breast implants. The FDA banned the silicone gel type in 1992 because of fears they might cause breast cancer, lupus and other disorders. FDA regulators said they “respectfully disagree” with the conclusions. Allergan and the other U.S. manufacturer of breast implants — Ideal Implant — did not receive warnings.

Source: National Post March 24, 2019 12:22 UTC